Log in to save to my catalogue

Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders

Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4001d4cd01d84144ae1f1803af53ce58

Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders

About this item

Full title

Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Drug design, development and therapy, 2021-01, Vol.15, p.3017-3026

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

This paper reviews the current literature available for the efficacy and safety of allopregnanolone agonists and discusses considerations for their place in therapy.
A literature search was conducted utilizing PubMed, clinicaltrials.gov, and the manufacturer's website.
One phase II trial and two phase III trials evaluating the efficacy and sa...

Alternative Titles

Full title

Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4001d4cd01d84144ae1f1803af53ce58

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4001d4cd01d84144ae1f1803af53ce58

Other Identifiers

ISSN

1177-8881

E-ISSN

1177-8881

DOI

10.2147/DDDT.S240856

How to access this item